van Trommel N - Search Results

1

Practical clinical guidelines of the EOTTD for treatment and referral of gestational trophoblastic disease.

Lok C, van Trommel N, Massuger L, Golfier F, Seckl M; Clinical Working Party of the EOTTD. Lok C, et al. Among authors: van trommel n. Eur J Cancer. 2020 May;130:228-240. doi: 10.1016/j.ejca.2020.02.011. Epub 2020 Apr 1. Eur J Cancer. 2020. PMID: 32247260 Free article.

2

The curative effect of a second curettage in persistent trophoblastic disease: a retrospective cohort survey.

van Trommel NE, Massuger LF, Verheijen RH, Sweep FC, Thomas CM. van Trommel NE, et al. Gynecol Oncol. 2005 Oct;99(1):6-13. doi: 10.1016/j.ygyno.2005.06.032. Gynecol Oncol. 2005. PMID: 16085294

3

Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios.

van Trommel NE, Sweep FC, Schijf CP, Massuger LF, Thomas CM. van Trommel NE, et al. Eur J Endocrinol. 2005 Oct;153(4):565-75. doi: 10.1530/eje.1.01997. Eur J Endocrinol. 2005. PMID: 16189178

4

Second curettage in persistent trophoblastic disease (PTD): the need for univocal definition of PTD.

van Trommel NE, Thomas CM, Massuger LF, Sweep FC. van Trommel NE, et al. Gynecol Oncol. 2005 Oct;99(1):250-1; author reply 251. doi: 10.1016/j.ygyno.2005.03.012. Gynecol Oncol. 2005. PMID: 16224821 No abstract available.

5

Early identification of resistance to first-line single-agent methotrexate in patients with persistent trophoblastic disease.

van Trommel NE, Massuger LF, Schijf CP, ten Kate-Booij MJ, Sweep FC, Thomas CM. van Trommel NE, et al. J Clin Oncol. 2006 Jan 1;24(1):52-8. doi: 10.1200/JCO.2005.03.3043. J Clin Oncol. 2006. PMID: 16382113

6

Clinical utility of hyperglycosylated hCG in serum taken before hydatidiform mole evacuation to predict persistent trophoblastic disease.

Duc HN, van Trommel NE, Sweep FC, Massuger LF, Thomas CM. Duc HN, et al. Among authors: van trommel ne. Int J Biol Markers. 2006 Jan-Mar;21(1):45-9. Int J Biol Markers. 2006. PMID: 16711513

7

Comparison of human chorionic gonadotropin +beta and invasive trophoblast antigen disappearance rates in serum after evacuation of molar pregnancy.

Van Trommel NE, Sweep FC, Ross HA, Massuger LF, Thomas CM. Van Trommel NE, et al. Int J Mol Med. 2006 Oct;18(4):705-11. Int J Mol Med. 2006. PMID: 16964426

8

Early identification of persistent trophoblastic disease with serum hCG concentration ratios.

van Trommel NE, Ngo Duc H, Massuger LF, Schijf CP, Sweep CG, Thomas CM; Dutch Working Party on Trophoblastic Tumors. van Trommel NE, et al. Int J Gynecol Cancer. 2008 Mar-Apr;18(2):318-23. doi: 10.1111/j.1525-1438.2007.00993.x. Epub 2007 May 19. Int J Gynecol Cancer. 2008. PMID: 17511799

9

Early identification of treatment resistance in GTN.

van Trommel NE, Massuger LF, Span PN, Sweep FC, Thomas CM. van Trommel NE, et al. Lancet Oncol. 2007 Oct;8(10):866-7. doi: 10.1016/S1470-2045(07)70296-6. Lancet Oncol. 2007. PMID: 17913658 No abstract available.

10

[Trophoblastic diseases].

ten Kate-Booij MJ, Lok CA, Verheijen RH, Massuger LF, van Trommel NE. ten Kate-Booij MJ, et al. Among authors: van trommel ne. Ned Tijdschr Geneeskd. 2008 Oct 11;152(41):2219-24. Ned Tijdschr Geneeskd. 2008. PMID: 19009808 Review. Dutch.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters